Cellular uptake of modified oligonucleotides: fluorescence approach

[1]  Pierre-Yves Turpin,et al.  Intracellular uptake of modified oligonucleotide studied by two fluorescence techniques. , 2004, Biopolymers.

[2]  P. Praus,et al.  Spectral Decomposition of Intracellular Complex Fluorescent Signals Using Multiwavelength Phase Modulation Lifetime Determination , 2000, Journal of Fluorescence.

[3]  Jens Kurreck,et al.  Antisense technologies. Improvement through novel chemical modifications. , 2003, European journal of biochemistry.

[4]  E. Kočišová,et al.  A frequency Domain Phase/Modulation Technique for Intracellular Multicomponent Fluorescence Analysis: Technical Approach and Pharmacological Applications , 2003 .

[5]  E. Kočišová,et al.  Spectral decomposition of intracellular complex fluorescence using multiple-wavelength phase modulation lifetime determination: technical approach and preliminary applications. , 2002, Biopolymers.

[6]  O. Seksek,et al.  A cationic derivative of amphotericin B as a novel delivery system for antisense oligonucleotides. , 2000, Antisense & nucleic acid drug development.

[7]  V. Vlassov,et al.  Oligonucleotides and polynucleotides as biologically active compounds. , 1997, Progress in nucleic acid research and molecular biology.

[8]  R. Wagner,et al.  In pursuit of antisense. , 1996, Nature.

[9]  R. Duncan,et al.  Stability of antisense oligonucleotides during incubation with a mixture of isolated lysosomal enzymes , 1996 .

[10]  P. Glazer,et al.  Facilitating oligonucleotide delivery: helping antisense deliver on its promise. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[11]  P. Glazer,et al.  Mutagenesis in Mammalian Cells Induced by Triple Helix Formation and Transcription-Coupled Repair , 1996, Science.

[12]  C. Hélène,et al.  Rational design of sequence-specific oncogene inhibitors based on antisense and antigene oligonucleotides. , 1991, European journal of cancer.

[13]  E. Uhlmann,et al.  Antisense oligonucleotides: a new therapeutic principle , 1990 .